Waltham, Massachusetts-based global diagnostic device and service provider, Alere Inc., announced the opening of a diagnostics manufacturing facility in Manesar, in the northern state of Haryana, which will produce rapid tests for the detection of infectious diseases including Malaria, Dengue and HIV and export them across the Asia Pacific region. The 180,000 square foot factory, in which the company has currently invested $25 million, will initially employ a staff of y 300 people; it can double its capacity as needed.
Namal Nawana, CEO & President, Alere Inc., said, “Alere’s new facility will support the goals of our ‘Make in India’ initiative, which seeks to transform India into a global manufacturing hub. Efforts to foster and expand India’s medical device sector are important not only to our economic growth, but also to improve the health of the people of India. The new state-of-the-art facility will not only help us meet the needs of the burgeoning domestic market but also help us cater to the APAC market.”
BioSpectrum reports that Alere Inc., aims to achieve its target of $ 149 million (Rs. 1,000 crore) over the next 3 years equipped with portfolio innovative Point-Of-Care-Testing diagnostic products that will focus on improving health outcomes. The company will continue to focus on cardiometabolic diseases, infectious diseases and toxicology solutions in India by providing affordable, sensitive, specific, user-friendly, devices for disease control & management.
